EMICIZUMAB — all Canadian products
6 DINs
6 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is EMICIZUMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02479621 | HEMLIBRA | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous | EMICIZUMAB 30 MG | Marketed | |
| 02479648 | HEMLIBRA | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous | EMICIZUMAB 60 MG | Marketed | |
| 02479656 | HEMLIBRA | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous | EMICIZUMAB 105 MG | Marketed | |
| 02479664 | HEMLIBRA | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous | EMICIZUMAB 150 MG | Marketed | |
| 02556049 | HEMLIBRA | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous | EMICIZUMAB 12 MG | Marketed | |
| 02556057 | HEMLIBRA | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous | EMICIZUMAB 300 MG | Marketed |
Browse other molecules: